
Loading, please wait...

Loading, please wait...

The weight management landscape features many miracle solutions and trending diets. Diabetologist Dr. Anoop Misra, in his new book, addresses the prevailing Diabetes Reversal Myths and dietary fads currently sweeping India. His work, Smart Calories and Common Sense, emphasizes that while trends like Keto offer rapid results, their long-term viability remains questionable. Consequently, clinicians must guide patients toward evidence-based strategies instead of unsustainable fads.
The concept of remission has gained significant traction, yet it remains often misunderstood. Dr. Misra clarifies that while remission is possible for some, it is not a universal guarantee. Patients with long-standing diabetes or significant pancreatic damage may find aggressive dietary interventions risky. Furthermore, the book stresses that remission requires intensive, supervised interventions. Therefore, the narrative of a simple cure often ignores individual metabolic variability and disease profiles.
Ketogenic diets focus on high fat and low carbohydrate intake to trigger weight loss. Although effective in the short term, they are difficult to sustain for most individuals. Dr. Misra warns of side effects such as fatigue and potential cardiovascular risks. Similarly, intermittent fasting shows weight loss results comparable to standard calorie restriction. However, research has not yet established its long-term safety for the Indian population. Therefore, medical supervision is essential when attempting these restrictive eating patterns.
GLP-1 receptor agonists, such as semaglutide, are transforming obesity management. These medications significantly improve metabolic parameters and reduce weight. Nevertheless, they are not a substitute for sustained lifestyle changes. Dr. Misra notes that these drugs must be prescribed judiciously due to cost and side effects. Additionally, the rise of generics in India raises concerns about quality and regulation. Thus, physicians should ensure patients understand that medication serves as an adjunct, not a replacement, for healthy habits.
Q1: Is diabetes reversal possible for everyone?
No, not everyone is a candidate for remission. It is most achievable for those with recently diagnosed diabetes and without significant pancreatic damage.
Q2: What are the primary risks of the Keto diet?
Keto diets can lead to fatigue, digestive issues, and potential heart health risks if followed without medical supervision or for extended periods.
Q3: Should weight-loss drugs be used without lifestyle changes?
No, GLP-1 drugs and other medications require sustained lifestyle modifications to be effective and safe in the long term.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Dr. Anoop Misra’s new book, Smart Calories and Common Sense, critiques Keto, fasting, and GLP-1 drugs while addressing diabetes reversal myths in India....
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today